FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Jubilant Cadista Pharmaceuticals Losartan Potassium and Hydrochlorothiazide Recall

Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bo…

Jubilant Cadista Pharmaceuticals Inc. · Salisbury, MD

Risk level
Class II
Reported by FDA
Aug 6, 2014
Recall ID
D-1500-2014
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Losartan Potassium and Hydrochlorothiazide starting Jul 11, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1500-2014 on Aug 6, 2014. Reason: Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.

Product description

Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90

Lot numbers, UPCs & expiration codes

Lot #14P0292, Exp 04/2016

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1500-2014
Classification
Class II
Status
Terminated
Recall initiated
Jul 11, 2014
FDA report date
Aug 6, 2014
Quantity
9,358 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1500-2014, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
68776
Address
207 Kiley Dr
Code information
Lot #14P0292, Exp 04/2016
Postal code
21801-2249
Report date
Aug 6, 2014
Product type
Drugs
Recall number
D-1500-2014
Classification
Class II
Recalling firm
Jubilant Cadista Pharmaceuticals Inc.
Product quantity
9,358 bottles
Termination date
Sep 15, 2016
Reason for recall
Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Jul 11, 2014
Initial firm notification
Telephone
Center classification date
Jul 31, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1500-2014, published Aug 6, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls